Loss-of-function mutations in the tumor suppressor gene APC initiate neoplastic transformation, while subsequent activating mutations in the oncogene KRAS are frequently associated with the progression from benign adenoma to dysplastic adenocarcinoma [32]. This evidence concerns the gene KRAS and adenoma.